Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PLAVIX SANOFI-AVENTIS CANADA INC Actual shortage 75MG Updated Report 2023-12-11 205398
PARIET, ENTERIC-COATED TABLET 20MG JANSSEN INC Anticipated shortage 20MG Updated Report 2023-12-11 212763
PARIET, ENTERIC-COATED TABLET 10MG JANSSEN INC Anticipated shortage 10MG Updated Report 2023-12-11 212758
METRONIDAZOLE INJECTION, USP BAXTER CORPORATION Actual shortage 5MG Updated Report 2023-12-11 212704
ESTRADOT 75 SANDOZ CANADA INCORPORATED Actual shortage 75MCG Updated Report 2023-12-11 210056
SANDOZ AMOXI-CLAV TABLET SANDOZ CANADA INCORPORATED Actual shortage 125MG 875MG Updated Report 2023-12-11 210829
SANDOZ EZETIMIBE SANDOZ CANADA INCORPORATED Anticipated shortage 10MG New Report 2023-12-11 213011
SANDOZ ENALAPRIL SANDOZ CANADA INCORPORATED Anticipated shortage 4MG New Report 2023-12-11 213008
SANDOZ ATORVASTATIN SANDOZ CANADA INCORPORATED Anticipated shortage 40MG New Report 2023-12-11 213005
SANDOZ ATORVASTATIN SANDOZ CANADA INCORPORATED Anticipated shortage 40MG New Report 2023-12-11 213002
ACETYLCYSTEINE SOLUTION SANDOZ CANADA INCORPORATED Anticipated shortage 200MG New Report 2023-12-11 212999
PROTAMINE SULFATE INJECTION USP SANDOZ CANADA INCORPORATED Actual shortage 10MG Updated Report 2023-12-11 210852
SANDOZ DAPAGLIFLOZIN SANDOZ CANADA INCORPORATED Actual shortage 10MG Updated Report 2023-12-11 210838
CLINDAMYCIN INJECTION USP SANDOZ CANADA INCORPORATED Actual shortage 150MG Updated Report 2023-12-11 205789
SANDOZ CIPROFLOXACIN / DEXAMETHASONE SANDOZ CANADA INCORPORATED Actual shortage 0.1% 0.3% Updated Report 2023-12-11 212439
SANDOZ IRBESARTAN HCT SANDOZ CANADA INCORPORATED Actual shortage 12.5MG 150MG Updated Report 2023-12-11 209216
MOUNJARO ELI LILLY CANADA INC Anticipated shortage 12.5MG Updated Report 2023-12-11 210461
CYTOGAM KI BIOPHARMA LLC Resolved 2500MG Updated Report 2023-12-10 185788
FLUNARIZINE AA PHARMA INC Resolved 5MG Updated Report 2023-12-10 176139
IRINOTECAN HYDROCHLORIDE INJECTION USP PFIZER CANADA ULC Actual shortage 20MG Updated Report 2023-12-10 212033

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
!T3 GLUCAGON ELI LILLY CANADA INC To be discontinued 1MG Updated Report 2023-12-11 165759
LIBTAYO SANOFI-AVENTIS CANADA INC Discontinued 250MG Updated Report 2023-12-09 212566
LIDEX BAUSCH HEALTH, CANADA INC. Discontinued 0.05% New Report 2023-12-08 212804
LODALIS BAUSCH HEALTH, CANADA INC. Discontinued 3.75G New Report 2023-12-08 212799
NUCALA GLAXOSMITHKLINE INC Discontinued 100MG New Report 2023-12-07 212755